The mTORC2/Akt/NFκB Pathway-Mediated Activation of TRPC6 Participates in Adriamycin-Induced Podocyte Apoptosis
Author(s) -
Haitao Zhang,
Weiwei Wang,
Lihong Ren,
Xia-Xia Zhao,
ZhiHui Wang,
De-Li Zhuang,
Yun-Nuo Bai
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000453163
Subject(s) - trpc6 , gene knockdown , protein kinase b , apoptosis , pi3k/akt/mtor pathway , podocyte , cancer research , mtorc1 , mg132 , chemistry , propidium iodide , microbiology and biotechnology , biology , endocrinology , receptor , programmed cell death , kidney , biochemistry , proteasome inhibitor , transient receptor potential channel , proteinuria
Although increased expression and gain function of transient receptor potential cation channel 6 (TRPC6) has been associated with the pathogenesis of some proteinuric glomerular diseases, it remains elusive how TRPC6 participates in the process of podocyte damage.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom